In the following video, Fool contributor Maxxwell Chatsko talks with health care analyst Max Macaluso and recaps the latest earnings results from the pharmaceutical industry. These companies each saw healthy gains in operating results and have big upcoming launches, such as Invokana from Johnson & Johnson (NYSE:JNJ) and Eliquis from Pfizer (NYSE:PFE). Nonetheless, investors will need to keep a long-term focus when viewing these complex pharmaceutical giants.
Maxx has been a contributor to Fool.com since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.
- May 13, 2013 at 1:50PM
- Health Care